Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
CDK15
Cyclin-dependent kinase 15 |
2 |
0 |
High-throughput |
0.602 | High |
|
MMTA2
Multiple myeloma tumor-associated protein 2 |
1 |
0 |
High-throughput |
0.513 | High |
|
MBNL1
Muscleblind-like protein 1 |
1 |
0 |
High-throughput |
0.513 | High |
|
PDP2
[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial |
1 |
0 |
High-throughput |
0.513 | High |
|
PHF11
PHD finger protein 11 |
1 |
0 |
High-throughput |
0.513 | High |
|
RN115
E3 ubiquitin-protein ligase RNF115 |
1 |
0 |
High-throughput |
0.513 | High |
|
PINK1
Serine/threonine-protein kinase PINK1, mitochondrial |
1 |
1 |
High-throughput |
0.489 | High |
|
IP6K3
Inositol hexakisphosphate kinase 3 |
2 |
0 |
High-throughput |
0.328 | High |
|
MYCB2
E3 ubiquitin-protein ligase MYCBP2 |
2 |
0 |
High-throughput |
0.324 | High |
|
OR2A4
Olfactory receptor 2A4 |
1 |
0 |
High-throughput |
0.279 | Low |
|
ADT3
ADP/ATP translocase 3 |
1 |
0 |
High-throughput |
0.279 | Low |
|
CCR1
C-C chemokine receptor type 1 |
1 |
0 |
High-throughput |
0.279 | Low |
|
STX17
Syntaxin-17 |
1 |
0 |
High-throughput |
0.279 | Low |
|
2ABB
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform |
1 |
0 |
High-throughput |
0.279 | Low |
|
GABPA
GA-binding protein alpha chain |
1 |
0 |
High-throughput |
0.279 | Low |
|
CR021
UPF0711 protein C18orf21 |
1 |
0 |
High-throughput |
0.279 | Low |
|
SARAF
Store-operated calcium entry-associated regulatory factor |
1 |
0 |
High-throughput |
0.279 | Low |
|
PLCA
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha |
1 |
0 |
High-throughput |
0.279 | Low |
|
WDR54
WD repeat-containing protein 54 |
1 |
0 |
High-throughput |
0.279 | Low |
|
SSUH2
Protein SSUH2 homolog |
1 |
0 |
High-throughput |
0.279 | Low |
|
FBXW8
F-box/WD repeat-containing protein 8 |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024